Google Maps

NCT07742605

Overview

NCT ID: NCT07742605
Lead Sponsor: Xula Wellness LLCINDUSTRY
Official Title: A Clinical Trial to Evaluate the Effects of a Supplement on Cognitive Performance
Brief Summary: This study evaluates the effects of the Xula Herbs Mind Food supplement on cognitive performance in adults aged 25-70 who report difficulty concentrating, memory challenges, brain fog, and low productivity. The trial is a single-arm, open-label, virtual study conducted over 6 weeks in 35 participants.

Participants will use the test product three times daily (sprayed three times under the tongue, at least 30 minutes before a meal, and not after 6 pm) for the duration of the study. Cognitive performance will be assessed via a Cognitive Battery Test at Baseline and Week 6, and self-reported questionnaires will be completed at Baseline, Week 2, Week 4, and Week 6.
Conditions: Cognitive Impairment
Brain Fog
Memory Difficulties

Status and Timeline

Status: Completed
Last Update Posted: Aug 3, 2026Actual
Start Date: Jul 11, 2025Actual
Primary Completion Date: Sep 30, 2025Actual
Completion Date

Participation Criteria

Ages Eligible for Study: Adult (18-64)Older Adult (65+)
Sexes Eligible for Study: All
Accepts Healthy Volunteers?: No
Eligibility Criteria: Inclusion Criteria:

Be male or female.

Be aged 25-70.

Anyone experiencing issues with all of the following over the past four weeks: difficulty concentrating or low mental sharpness

difficulty with memory

experiences of brain fog or lack of mental clarity

feeling of low productivity.

Willing to refrain from taking any new products, over-the-counter medications, or supplements that may affect cognitive ability during the test period.

If taking any products, over-the-counter medications, or supplements that may affect cognitive ability, has been doing so consistently for at least three months and is willing to maintain this routine for the duration of the study.

Anyone who is generally healthy - does not live with any uncontrolled chronic disease.

Exclusion Criteria:

Anyone with pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders.

Anyone with any allergies or sensitivities to any of the study product ingredients.

Anyone who is pregnant, breastfeeding, or trying to conceive (or who will be at any point during the study period).

Anyone unwilling to follow the study protocol.

Anyone diagnosed with a neurodegenerative condition.

Anyone taking an anticoagulant (also commonly referred to as a blood thinner) prescription medication.

Anyone with liver disease or kidney disease.

Anyone taking hormonal birth control or contraceptives.

Anyone with a history of substance abuse.

Anyone who drinks heavily (8 or more alcoholic drinks per week for women or 15 or more alcoholic drinks per week for men).

Currently partaking in another research study or will be partaking in any other research study at any point during this study's duration.

Study Plan

Study Type: Interventional
Phase: Not Applicable
Enrollment: 35Actual
Primary Purpose: Treatment
Allocation: N/A
Interventional Model: Single Group Assignment
Masking: None (Open Label)

Contacts and Locations

Central Contacts: No data available
Locations: Citruslabs

Overview

Status and Timeline

Participation Criteria

Study Plan

Contacts and Locations

Similar Studies